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SUMMARY

microRNAs were recently found to be regulators of
the host response to infection by apicomplexan parasites. In this study, we identified two immunomodulatory microRNAs, miR-146a and miR-155, that
were coinduced in the brains of mice challenged
with Toxoplasma in a strain-specific manner. These
microRNAs define a characteristic fingerprint for
infection by type II strains, which are the most prevalent cause of human toxoplasmosis in Europe and
North America. Using forward genetics, we showed
that strain-specific differences in miR-146a modulation were in part mediated by the rhoptry kinase,
ROP16. Remarkably, we found that miR-146a deficiency led to better control of parasite burden in
the gut and most likely of early parasite dissemination in the brain tissue, resulting in the long-term survival of mice.
INTRODUCTION
Toxoplasma gondii is a widespread obligate intracellular protozoan parasite causing toxoplasmosis, a potentially severe disease in immunocompromised or congenitally infected humans.
Central to transmission and pathogenesis is the ability to traffic
to the CNS following host infection and to undergo transformation from the rapidly dividing, disease-causing tachyzoite to a
long-lived, slow-dividing bradyzoite contained within tissue
cysts. This bradyzoite cyst sustains establishment of chronic
infection. Bradyzoites can spontaneously reconvert back to
tachyzoites, but their dissemination is effectively prevented by
the immune system. Upon host cell invasion, Toxoplasma parasites grow inside a parasitophorous vacuole (PV), a dynamic
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niche shaped by the tachyzoite to support its growth. Host
stromal and immune cells respond to infection with profound
transcriptional changes, including genes involved in mounting
Th1-type immune response to infection (Jensen et al., 2011;
Hunter and Sibley, 2012). Several strain-specific parasite effectors are secreted into the host cells where they neutralize cell
autonomous immune defenses or subvert gene expression (Howard et al., 2011; Hunter and Sibley, 2012). Many known
secreted molecules are either released from rhoptry secretory
organelles early in host cell invasion (e.g., ROP16, Saeij et al.,
2007) or are released from dense granules (e.g., GRA24, Braun
et al., 2013).
In addition, apicomplexan parasites may also interfere with
host miRNA populations in a parasite-specific manner, suggesting this RNA silencing pathway as a way of reshaping cellular
environment (Hakimi and Cannella, 2011). Previous work also
suggests that miRNA-based regulatory pathways may
contribute to the mounting of host cell responses/defenses
(e.g., the inflammatory response) (Ding and Voinnet, 2007).
The present study confirms that Toxoplasma alters the host
cell miRNA profile through a mechanism that requires live parasites that are able to invade and divide (Zeiner et al., 2010).
Notably, we now describe significant and exclusive upregulation by cystogenic strains (type II) of miR-146a expression, a
key inflammatory response regulator (Taganov et al., 2006).
Using forward genetics, we show that strain-specific differences in miR-146a expression modulation are controlled by
the parasite-secreted kinase ROP16. Furthermore, miR-146a
ablation affects early parasite burden, leading to significant differences in interferon (IFN)-g production and better survival in
normally susceptible C57BL/6 mice. Last, mice challenged
with type II strains had higher brain levels of miR-146a but
also of miR-155, another immunoregulatory RNA (Lindsay,
2008). Collectively, these data uncover a microRNA signature
that typifies Toxoplasma long-term persistence and latency in
the host brain.

RESULTS
Specific Alteration of Host Cell miRNA Profile
by Toxoplasma Infection
In this study, we profiled the steady-state levels of cellular
mature miRNAs from primary human foreskin fibroblasts (HFF)
infected with the virulent type I (RH) strain (Figure S1A;
Table S1). Overall, our data mirror those published previously
showing that Toxoplasma alters the levels of 5%–10% of
host miRNAs in tachyzoites-infected human fibroblasts (Zeiner
et al., 2010). We compared host miRNA expression levels in cells
infected with Toxoplasma, Theileria, or Cryptosporidium using
our data set and previously published data sets, and this revealed that these apicomplexan parasites modulate the expression of a restricted panel of miRNAs in a specific manner, most
likely in order to suit their respective biology. This can be illustrated by miR-155, a microRNA implicated in immune response
(Lindsay, 2008) that was strongly induced by both Toxoplasma
(Figures S1B) and Theileria (Marsolier et al., 2013) while being unaffected by Crytosporidium infection (Zhou et al., 2009).
Patterns of expression of host microRNA were linked to the time
course of infection and multiplicity of infection (MOI) (Figure S1C;
data not shown). Although the levels of miR-16, -26a, -29a, and
-221 marginally decreased 6 hr postinvasion and showed a clear
inhibition at 15 and 24 hr, miR-1246 increased rapidly at 6 hr and
remained high thereafter (Figure S1C). Control cells exposed to
heat-killed tachyzoites displayed a miRNA expression profile
similar to that of uninfected control samples indicating that interference with the host RNA silencing machinery required live parasites, still able to invade and divide, rather than through signaling
molecules diffusing in the cell-culture media (Figure S1C; data not
shown). Overall, these changes are a specific response to Toxoplasma infection because the levels of the aforementioned
miRNAs remain unchanged in cells infected with Neospora
caninum, a close relative of Toxoplasma (Figure S1C).
Toxoplasma Infection Modulates Host miRNAs
Biogenesis at Multiple Levels
Theoretically, interference with the miRNA pathway could occur
at the levels of miRNA transcription, biogenesis, or activity (Hakimi and Cannella, 2011). In this respect, the inhibition of
miR-16, -26a, and -29a may occur at the transcriptional level
because the level of their precursors (pre-miRNA) decreased
simultaneously postinvasion (Figure S1C). A common feature
of these three microRNAs is that they are classified as repressed
by the oncogenic transcription factor c-Myc (Chang et al., 2008).
It appears that they belong to a larger panel of miRNAs defined
as core Myc-regulated genes (20 miRNAs) that are effectively
repressed 6 hr postinvasion by Toxoplasma (Figure S2A). This
is consistent with the induction of the Myc protein by Toxoplasma (Figure S2B). Although acting at the transcriptional level,
Toxoplasma infection also potentiates the Dicer-mediated processing of host cell miRNAs. For instance, the mature miR1246 drastically increased with the expected decrease of its precursor, suggesting that infection by live Toxoplasma tachyzoites
affects dicer processing (Figure S1C). This response reminds us
of the effect of the RNA binding protein Lin-28 on the processing
of the microRNA Let-7 (Rybak et al., 2008).

Toxoplasma Upregulates miR-146a Levels
in a Strain-Specific Manner
We next considered whether altered miRNA levels were relevant
to differences in pathogenesis among strain types. We
compared the levels of cellular microRNAs in human fibroblasts
infected with type I (RH) strain, which normally does not make
tissue cysts, to the cystogenic type II (ME49) strain (Figure 1A;
Table S2). Among the miRNAs differentially expressed across
strains, miR-146a was substantially and significantly induced
by ME49 tachyzoites, whereas the RH parasites did not affect
its expression (Figures 1A, 1B, and S2C). The miR-146a miRNA
family has two evolutionary conserved genes: miR-146a and
miR-146b, which are located on separate chromosomes, in quite
unrelated sequence contexts, but differ in their mature sequence
by only two nucleotides at the 30 end (Figure S3A) (Taganov et al.,
2006). We next assessed the kinetics of both miR-146a and miR146b to discriminate between miR-146 family paralogs in human
and murine cells infected with Toxoplasma strains of the three
main clonal lineages (Figures 1C and 1D). Twenty-four hours
postinvasion, miR-146a was dramatically induced (30- to 60fold) by type II (PRU and ME49) strains compared to human fibroblasts infected with type I (RH and GT1) or type III (CTG) strains
(Figures 1C). miR-146a upregulation by ME49 started 6 hr postinvasion and was most dramatic after 24 hr (Figure 1D). This
regulation is likely to be at the level of transcription because a
similar upregulation was observed at the level of the primary
miR-146a transcripts (pri-miR-146a) in cells infected with
type II parasites (Figure 1E). Additionally, the levels of miR146a increased slightly but exclusively in response to infection
by a type II strain in human embryonic kidney 293 and astrocytoma U373 cells, reflecting the robustness of this phenotype
using different host cell types (Figures S2D and S2E). Whereas
the amounts of mature miR-146a were increased by Toxoplasma
infection, miR-146b levels remained unchanged (Figure 1D),
suggesting that this miRNA family has a rather specific mode
of regulation of expression involving more than one point of
control.
miR-146a is widely expressed throughout the hematopoietic
system (Boldin et al., 2011). Its expression is initially low in precursor cells and increases with maturation and activation, typically in
response to Toll-like receptor (TLR) agonists. In line with previous
findings, we found that the levels of miR-146a in murine bone
marrow-derived macrophages (BMDMs) and in human primary
astrocytes were significantly higher when compared to fibroblasts (Figure S2F; data not shown). However, Toxoplasma did
not alter miR-146a expression in BMDMs, nor in astrocytes,
most likely because the maximum threshold limit was already
reached in these cells. In summary, miR-146a expression was
distinctively upregulated in a wide range of nonhematopoietic
cells following infection by type II strains of Toxoplasma.
Toxoplasma Type II Strains Induce miR-146a, an NF-kBDependent Gene, in a GRA15-Independent Fashion
miR-146a was initially found to be a NF-kB-dependent gene (Figure S3A; Taganov et al., 2006). This response is consistent with
the strain-specific activation of the host NF-kB pathway by Toxoplasma (Rosowski et al., 2011). Indeed, type II tachyzoites, unlike
types I and III, activate the nuclear translocation of NF-kB p65
Cell Reports 6, 928–937, March 13, 2014 ª2014 The Authors 929

Figure 1. Expression Profiling of Mature miRNAs in Human Fibroblasts following Infection by Type I (RH) versus Type II (ME49) Strains
(A) Heatmap of quantitative miRNA profiling of RH- versus ME49-infected HFF cells. Hierarchical clustering was performed on the microRNAs that were
differentially expressed between the two groups (n = 3 samples per strain). Gene expression values were mean log2 transformed and median centered for
clustering. The scale of the heatmap is presented as fold change from the median value. The miRNAs list can be found in Table S2.
(B) Northern blot analysis of cellular miRNA levels in human fibroblast cells after 24 hr of mock treatment (u.i) or upon infection with type I (RH) and type II (ME49)
strains. Each infection was performed in triplicate. To control for loading, blots were stripped and rehybridized with the indicated miRNA and control probe. RNA
markers are on the left.
(C) Quantitative RT-PCR (qRT-PCR) analysis of both miR-146a and miR-155 levels in HFF cells left uninfected (u.i) or infected with type I (RH), type II (PRU and
ME49), or type III (CTG) strains. microRNA levels were normalized by RNU24 levels. Mean values and SDs from three independent experiments are shown.
(D and E) Time-dependent expression of (D) miR-146a, miR-146b and (E) primary transcripts pri-miR-146a in HFF cells after Toxoplasma type I (RH) and type II
(ME49) infections. microRNA levels were assessed by qRT-PCR and normalized by RNU24 levels.
Mean values and SDs from three independent experiments are shown. See also Figures S1 and S2 and Tables S1 and S2.

(RelA) promoting its transcriptional activity, which may account
for the type II-dependent induction of miR-146a. The dense
granule protein GRA15 was reported as sufficient to mediate
the effect as it intersects the NF-kB pathway downstream of
MyD88, interleukin (IL)-1R, and TRIF but upstream of TRAF6
and the IKK complex (Rosowski et al., 2011). We therefore asked
whether GRA15 might be involved in miR-146a induction by
Toxoplasma. However, GRA15 deletion in the type II (Pru A7)
did not significantly limit miR-146a induction in the infected fibroblast cells (Figure S3B). Similarly, ectopic expression of a type II
allele of GRA15 in a type I strain (Figure S3C), while activating
NF-kB p65 (Rosowski et al., 2011; data not shown), did not alter
930 Cell Reports 6, 928–937, March 13, 2014 ª2014 The Authors

miR-146a levels (Figure S3D). Therefore, miR-146a induction by
Toxoplasma is independent of GRA15. However, the fact that
GRA15II has an effect on some NF-kB family members (e.g.,
p65 subunit) but not on others (Rosowski et al., 2011) indicates
that alternative parasite-derived factors other than GRA15
are likely involved in NF-kB-dependent (p65-independent)
miR-146a regulation.
Genome-wide Scan of the miR-146a Phenotype Reveals
a Single Major QTL
To further assess if the increase of miR-146a levels in cells infected with Toxoplasma takes place via an active mechanism

Figure 2. Genome-wide Scan for Association of miR-146a Expression with Toxoplasma Genetic Markers Reveals a Single Major QTL
(A) Expression levels of miR-146a in the parental lines (type I, GT1, and type II, ME49) and 27 F1 progeny were assessed by qRT-PCR. Data are displayed as fold
difference relative to the uninfected cells. microRNA levels were normalized by RNU24 levels. Mean values and SDs from three independent experiments are
shown.
(B) Plots indicate the log-likelihood association of expression of miR-146a (solid line) with markers aligned across the entire Toxoplasma genome in chromosome
order. Significance levels determined by 3,000 permutations are indicated by horizontal lines (upper two lines are significant; lower line is suggestive).
(C) Fine mapping of the Toxoplasma chromosome VIIb locus involved in strain specific regulation of miR-146a. The GRA15 locus on chromosome X is shown as a
control. The QTL on VIIb is bound by genetic markers 55.m05046_at5 and 55.m010299_at3, which spans a region of 1.2 Mb including ROP16. The genotype for
each of the F1 progeny at the locus is indicated by the boxes color (type I, yellow, and type II, red).
See also Figure S3.

controlled by a parasite-derived product, we took advantage of
the aforementioned strain-specific difference to identify the
responsible gene(s). If the strain-specific regulation of miR146a has a genetic basis, it should accordingly segregate among
F1 progeny derived from a cross between two strains (II versus I
or III) that differ in its regulation. We therefore monitored miR146a levels in fibroblasts infected separately with 27 F1 progeny
derived from the I 3 II cross (Behnke et al., 2011). As expected,
the parental type II (ME49-FUDRR) strain induced significantly
higher miR-146a levels compared to the type I (GT1-SNFR)
strain, and among the recombinant progeny a range of distinct
phenotypes was observed (Figure 2A). Neither in vitro growth
(data not shown) nor virulence reported previously (Behnke
et al., 2011) were correlated with altered expression of miR146a among the progeny (Figure 2B). A genome-wide scan for
association of Toxoplasma genetic markers and the expression

level of miR-146a identified a single high-probability quantitative
trait loci (QTL) on chromosome VIIb with a high logarithm of odds
score (LOD = 10, Figure 2C) that was associated with >92% of
the inherited variation. Our data allowed us to restrict the
locus involved to a region between the genetic markers
55.m05046_at5 and 55.m010299_at3, representing a maximum
size of 1.2 Mb spanning 200 predicted protein encoding genes
(Figure 2B). Unexpectedly, we identified the Toxoplasma polymorphic ROP16 kinase as the most likely candidate (Figure 2B).
ROP16 is a specialized phosphotyrosine kinase that is released
from the rhoptries and injected into the host cell nucleus to activate STAT3/6 signaling pathways (Saeij et al., 2007). To
strengthen our genetic analysis, we repeated the genome-wide
scan using type II 3 III recombinant progeny (Khan et al., 2005)
and validated the QTL containing ROP16 for the miR-146a
phenotype (Figure S4). In addition, both genetic screens
Cell Reports 6, 928–937, March 13, 2014 ª2014 The Authors 931

Figure 3. Suppression of miR-146a Expression Is Mediated by Type I ROP16
(A) Immunoblotting detection of phosphoSTAT3(Y705) in nuclear cell lysates of HFF cells
left uninfected (u.i.) or infected (24 hr) with the
indicated strains. Toxofilin (parasite-specific) level
is shown as loading control.
(B and C) qRT-PCR analysis of miR-146a levels in
HFF cells left uninfected (u.i) or infected with (B)
type I or (C) type II Drop16 strains versus their
parental strains. microRNA expression levels were
normalized by RNU24 levels. Mean values and
SDs from three independent experiments are
shown.
(D) qRT-PCR analysis of miR-146a and miR-155
levels in HFF cells left uninfected (u.i) or infected
with wild-type type II strain PruA7 or PruA7
ectopically expressing a type I allele of ROP16.
microRNA expression levels were normalized by
RNU24 levels. Mean values and SDs from six independent experiments are shown.
(E) qRT-PCR analysis of miR-146a, described in
Figure 3D, was repeated during a 24 hr Toxoplasma infection time course. Mean values and
SDs from two independent experiments are
shown.
See also Figure S4.

confirmed that the type-II-dependent miR-146a induction was
clearly GRA15 independent (Figures 2B and S4B).

In this respect, ectopic expression of an
additional type I allele of ROP16 in the
type II (Pru) strain (ROP16-I, Saeij et al.,
2007) downregulated the level of miR146a by 2-fold (Figure 3D). These data
confirm that the type I allele of ROP16 suppresses miR-146a expression, whereas
the type II allele lacks this activity.
Although ROP16 is released from the
rhoptries in the early time of infection (1–
6 hr postinfection, Saeij et al., 2007), it
has a marked repressive effect on miR146a beyond 15 hr of infection (Figure 3E),
which is consistent with the ability of the
kinase to sustain phosphorylation of STAT3/6 in the late phase
of infection (Saeij et al., 2007).

ROP16 Suppresses miR-146a Expression in a StrainSpecific Fashion
To assess whether ROP16 was directly involved in the strainspecific activation of miR-146a, we deleted the gene in both
RHDku80 (type I) and PruDku80 (type II) strains (data not shown).
In line with previous reports (Saeij et al., 2007), we showed that
with parasites deleted for ROP16 in type I (RHDku80Drop16)
the sustained STAT3/6 tyrosine phosphorylation was no longer
observed (Figure 3A; data not shown). Deletion of ROP16 also
significantly enhanced the induction of miR-146a mediated by
Toxoplasma (Figure 3B). In marked contrast, ROP16 deletion in
type II (PruDku80) strain did not altered miR-146a levels (Figure 3C). Taken together, these data suggest that the kinase
acts as a repressor of the expression of this specific miRNA.

miR-146a and miR-155 Are Highly Induced in Mice Brain
Chronically Infected with Type II Strains
Because the induction of miR-146a in stromal cells was restricted
to infection by type II strains, which exhibit low virulence and are
cystogenic in mice, we further assessed whether this microRNA
might play a critical role in chronic toxoplasmosis. Accordingly,
we monitored the levels of eight microRNAs that were upregulated (miR-155 and miR-146a), downregulated (miR-150, miR101, let-7b, miR-29a, and miR-125b), or unchanged (miR-146b
and miR-132) following Toxoplasma infection of stromal cells
(Figures 1A and S1A). We assessed miRNA levels in the brain of
mice infected with a dose of parasites that allows survival through
acute infection (<14 days) and establishment of chronic infection
(Figure 4A). Surprisingly, miR-146a and miR-155 levels increased
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Figure 4. Evidence for a Typical microRNA Fingerprint in Cyst-Containing Brains of Mice Chronically Infected by Type II Toxoplasma Strains
(A) qRT-PCR analysis of selected microRNA levels in whole brains of Swiss mice left uninfected (n = 14 mice) or chronically infected (6–10 weeks postinfection) by
30–80 cysts of type II (ME49) strain (n = 14 mice) by intraperitoneal route. miRNA expression levels were expressed as normalized values using U6 snRNA as the
endogenous control. Mean values and SDs from three independent experiments are shown.
(B) Parasite burden and miRNAs expression were determined in wild-type Swiss mice intraperitoneally infected with a dose of 106 ME49 tachyzoites. Parasites
were enumerated by qPCR in the serum and from brain homogenates by qPCR at the indicated times after infection. The expression of the aforementioned
microRNA was assessed in the brain using qRT-PCR. miRNA expression levels were expressed as normalized values using U6 snRNA as the endogenous
control. Mean values and SDs from two animals in each group are shown.
(C) miRNA expression levels were assessed by qRT-PCR in brains of Swiss mice chronically infected by a type III (CTG) or a type II (ME49) Toxoplasma strains (105
tachyzoites by intraperitoneal route). miRNA expression levels were expressed as normalized values using U6 snRNA as the endogenous control. Mean values
and SDs from six to eight animals in each group are shown.
(D) Serological status by western blot analysis of mice left uninfected or infected as mentioned in Figure 4C.
(E) Parasite burden in the brain of infected Swiss mice (six to eight animals/group) described above. Toxoplasma DNA PCR assay was performed with brain tissue
sampled from mice at 7 weeks postinfection. *Significantly different (p < 0.05, Student’s t test).
See also Figure S5.

in the brain of chronically infected mice in a sustained fashion (6–
10 weeks postinfection [p.i.]), regardless of the genetic background of the mouse host (i.e., C57BL/6, BALB/c or Swiss) or
the type II parasite used (i.e., Pru A7, PruDku80, or ME49) (Figures
4A, S5A, and S5B). This miRNA signature is not a broad response
to the mere presence of parasites in the brain (detected 11 days
p.i.), but rather correlates well with the presence of fully developed cysts in the brain (>20 days p.i., Figure 4B) that persist
throughout the life of the chronically infected mice (up to 10 weeks
p.i.) (Figure 4A). In contrast, the relative levels of miR-155 and
miR-146a are distinctly low in the brains of mice chronically infected with the mouse-avirulent type III (CTG) strain (Figure 4C);

yet, this strain causes nonlethal chronic latent infection characterized by a proper positive serology (Figure 4D). The main difference with ME49 infection was that mice chronically infected with
CTG had a low number of cysts in their brain (Figure 4E), suggesting a likely relationship between cyst burden and the alteration of
miR-155 and miR-146a levels in the mice brain (Figures 4C and
4E). In this fashion, the high levels of miR-146a in mouse brains
with high cyst burden are consistent with the type II strainrestricted regulation of the microRNA in stromal cells.
Surprisingly, miR-155, while being induced in the brain only
when infected by type II strains (Figures 4A, S5A, and S5B), has
a strain-independent expression profile in stromal (Figure 1C)
Cell Reports 6, 928–937, March 13, 2014 ª2014 The Authors 933

Figure 5. miR-146a Expression Affects the
Control of Toxoplasma In Vivo
(A and B) Chronic cyst burden and microRNA
expression were assessed in Swiss mice left uninfected or infected by the parental strain ME49
(n = 11) and F1 I 3 II progeny strains SF18 (n = 13)
and SF28 (n = 8) using 105 tachyzoites and intraperitoneal route. (A) qRT-PCR analysis of miR146a and miR-155 levels were assessed in mice
brains. microRNA expression levels were normalized by U6 snRNA levels. Mean values and SDs
from eight to 13 animals in each group are shown.
(B) Cysts were enumerated by microscopy. *,
**Significantly different (p < 0.05, Student’s t test).
(C) C57BL/6 or C57BL/6 miR-146a/ mice were
intraperitoneally infected with a dose of 5 3 102
tachyzoites of PruA7 or PruA7+ROP16-I. Survival
was monitored. Significance was tested using logrank (Mantel-Cox) test and Peto & Peto modification of the Gehan-Wilcoxon test, *p = 8.13 3 106
and **p = 4.31 3 105 when compared to BL6 WT
infected by PruA7 WT parasite strain.
(D) qRT-PCR analysis of miR-146a levels were assessed in the brain of C57BL/6 WT and miR146a/ mice infected with PruA7 or PruA7+
ROP16-I and compared to those of uninfected
C57BL/6 WT mice. miRNA expression levels were
expressed as normalized values using miR-U6 as
the endogenous control. Mean values and SDs
from three independent experiments are shown.
(E) Peritoneal lavage fluid and serum were collected
on day 4 after infection of C57BL/6 or C57BL/6 miR146a/ mice that had received an intraperitoneal
(i.p.) dose of 103 PruA7 tachyzoites. Concentrations
of IFN-g were determined by ELISA. Data shown
are means ± SD with n = 3 individual mice per mice
genotype. Error bars represent SD from one
experiment. *Significantly different from WT (p <
0.05, Student’s t test).
(F) WT and miR-146/ C57BL/6 mice were i.p. infected with 103 PruA7 tachyzoites. Parasites were
enumerated using recovered i.p. contents at day 4
postinfection. Data shown are means ± SD (from
three mice per mouse genotype). *Significantly
different from WT (p < 0.05, Student’s t test).
See also Figure S5.

and phagocytic cells infected in vitro (Figure S2F). This suggests
that the miRNA fingerprint that marks cystogenesis in chronically
infected mice has multiple strain-dependent and -independent
determinants.
miR-146a belongs to a large family of circulating microRNA
that cofractionates in plasma and serum with exosomes (Arroyo
et al., 2011). We also provide evidence that miR-146a copurifies
with exosome vesicles isolated from supernatant of Toxoplasma-infected cells (Figures S5C–S5E) or brain (data not
shown), suggesting that the cell hosting the parasite might not
be the only cell where miR-146a is operating as a microRNA.
Cyst Burden Promotes miR-155 and miR-146a Induction
in the Brains of Chronically Infected Mice
Notwithstanding the ability of both type II and III strains of
T. gondii to establish latent infections, our data strongly indicate
934 Cell Reports 6, 928–937, March 13, 2014 ª2014 The Authors

that the induction of miR-146a or miR-155 was restricted to mice
with high chronic cyst burdens (Figure 4). This potentially raises
the question of whether ROP16 might be involved in this process, i.e., whether the kinase, by suppressing miR-146a induction (Figure 3) may contribute to lessen the cyst burden in the
brain. We therefore monitored the course of chronic toxoplasmosis in mice infected with either ME49 or SF18 (ROP16-I) and
SF28 (ROP16-II), two mouse-avirulent F1 progeny derived from
the type I 3 II cross (Behnke et al., 2011) that were initially characterized as low and high inducers of miR-146a expression in
stromal cells (Figure 2A). Our aim was to assess whether the ability of ROP16 to reduce miR-146a levels in the brain might impede
or promote cystogenesis. We first confirmed that SF28 differs
from SF18 by a strong induction of miR-146a in the brain (Figure 5A), thus mimicking the phenotype seen in stromal cells (Figure 2A) whereas miR-155 was equally induced by both strains

and at the same level as the parental ME49 strain (Figure 5A).
Moreover, mice infected with the SF18 strain (ROP16-I allele)
had markedly reduced cyst burden in the brain, compared with
mice infected with ME49 (type II control) or SF28 (ROP16-II allele)
strains (Figure 5B). These results mirror those using infection of
mice with a type III strain that was typified by a low number of
cysts and no induction of miRNAs whatsoever in the brain (Figures 4C and 4E).
miR-146a Ablation Promotes Host Resistance to
Toxoplasma Infection in Susceptible C57BL/6 Mice
miR-146a expression, while being efficiently induced by Toxoplasma, was shown to be persistently suppressed by strains expressing type I or III ROP16 alleles (Figures 4C and 5A). Given
the established role of the ROP16 in generating innate resistance to oral challenge (Jensen et al., 2013), we decided to
explore whether miR-146a influences host resistance during
infection. As reported before, challenge of C57BL/6 mice with
a transgenic type II strain expressing ROP16-I lead to better
survival compared to a control infection with the parental type
II Pru A7 strain (Figure 5C). To assess whether miR-146a was
also required for host protection, we challenged miR-146a/
knockout mice (described in Boldin et al., 2011) with 5 3 102
parasites of PruA7, and their survival was compared with that
of C57BL/6 control mice. miR-146a/ mice infected with the
PruA7 WT strain were more resistant as evidenced by the
40% survival during the acute and chronic state of infection
(50 days p.i., Figure 5C). However, this did not fully recapitulate
the phenotype of the type II (PruA7) strain expressing ROP16-I
(80% survival of challenged mice), thereby indicating that additional ROP16-regulated genes might contribute to promote host
resistance to Toxoplasma infection in susceptible C57BL/6
mice. Histopathological analysis of brains showed that miR146a/ mice challenged with PruA7 developed a mild meningoencephalitis, whereas WT mice had a more severe toxoplasmic encephalitis (TE) characterized by the presence of
significant numbers of parasites and areas of necrosis (data
not shown).
Possibly, miR-146a/ mice challenged with PruA7 survived
longer to TE than WT C57BL/6 mice because of changes in the
inflammatory response to the parasite. Indeed, amounts of
IFN-g were significantly lower in sera and peritoneal exudates
of infected miR-146a/ mice compared to their WT littermates
(Figure 5E). However, levels of other proinflammatory cytokines
like tumor necrosis factor (TNF)-a, IL-12, IL-1b, and IL-6 did
not change significantly (data not shown). In vitro assay using
tail-derived fibroblasts confirmed the above in vivo experiment
and showed that Toxoplasma (PruA7) infection failed to induce
IFN-g gene transcription in miR-146a/ tail-derived fibroblasts
(Figure S5G). The early difference in IFN-g production correlates
well with high parasite burden in peritoneal exudates of WT animals (Figure 5F), which subsequently may affect parasite
dissemination, load in the brain, and, ultimately, survival. It is
noteworthy that infection by a type II strain expressing a
ROP16-I allele led to a similar attenuation of IFN-g mRNA
expression to what observed in the absence of miR-146a (Figure S5G). Overall, these data indicate that miR-146a is required
for full inflammatory response in mice during toxoplasmosis.

DISCUSSION
As obligate intracellular parasites, apicomplexans deploy sophisticated mechanisms to profoundly reorganize the host cell
for their own needs. miRNAs were recently deemed as important
components of gene regulatory networks that play critical roles
in fine-tuning the host response to infection by several parasites
of the phylum (Hakimi and Cannella, 2011). Here, we provide
further evidence that the alteration of the microRNome mediated
by apicomplexan infection, both in terms of the repertoire and
the magnitude, is different from one parasite to another. Remarkably, we uncovered a reservoir of host genetic riboregulators
whose expression was tightly regulated by Toxoplasma infection. We thus showed that Toxoplasma infection increased the
levels of miR-146a and miR-155 in the brains of mice infected
by type II strains, which are competent to form cysts in the neural
tissue. In this regard, miR-146a/ ablation did not alter miR-155
levels in the brain of mice challenged with type II strain, suggesting that miR-155 induction in this tissue is miR-146a independent (Figure S5F). It is worth mentioning here that the levels of
miR-146b were neither influenced by Toxoplasma infection (Figure 1D) nor by the ablation of its paralog miR-146a (Figure S5F),
which illustrates the uniqueness of this RNA signature that typifies type II parasite persistence in the host.
Both miR-155 and miR-146a are regulated by the transcription
complex NF-kB, a component of a well-studied antipathogen
pathway. The increase in the levels of miR-146a and miR-155
is not, however, a broad NF-kB-dependent inflammatory
response to Toxoplasma infection. Several arguments support
this assertion. First, the prominent upregulation of their activation was only evident at day 20 p.i. when the cysts were readily
detectable and persisted in the chronic phase (Figures 4A and
4B). Second, other microRNAs whose expression was shown
to be dependent on NF-kB pathway activation, e.g., miR-132
(Taganov et al., 2006) and miR-125b (Zhou et al., 2009), were
not induced in the brain of chronically infected mice (Figure 4A).
Finally, Plasmodium berghei ANKA strain, which causes cerebral
malaria, selectively increases the levels of miR-150 but not those
of miR-155 in the brain of CBA mice p.i. (El-Assaad et al., 2011),
in quite the opposite fashion to infection by Toxoplasma (Figure 4A), suggesting that each apicomplexan infection is associated with a conserved, disease-specific signature of differentially expressed miRNAs.
We have clearly shown that the timing of miR-155 and miR146a induction in the mice brains coincides with the presence
of ‘‘mature’’ cysts and not with the mere occurrence of parasites
(Figure 4B), suggesting that bradyzoite-specific effector(s) might
operate in the host cell to regulate their levels. Meanwhile, we
provided strong evidence that GRA15, while directly modulating
the NF-kB pathway (Rosowski et al., 2011), did not alter the
levels of miR-146a, nor of miR-155 (Figure S3). Another candidate dense granule protein, GRA24, which directly activates
the MAPK p38a (Braun et al., 2013) pathway that interfaces
with NF-kB, did not appear to be associated with the phenotype
(data not shown).
Ablation of miR-146a expression in mice seems to play a role
in the control of early proliferation of Toxoplasma in the gut,
which was associated with a significant decrease in IFN-g levels
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in sera and peritoneal contents postinfection (Figures 5E and 5F).
These early inflammatory events may lead to lower CNS colonization and cyst burdens in miR-146a/ mice, which result in a
less severe encephalitis and delayed time to death as shown in
Figure 5C. Therefore, the higher survival rate of miR-146a-deficient mice might be more likely a consequence of early differences in parasite burden rather than a direct effect of miR146a action in the brain.
Nevertheless, infection by type II strains, that are prone to cyst
formation, systematically causes a significant increase in miR146a levels in mice brain. However, our results do not reveal
the primary mRNA target of the microRNA in the cyst-containing
brain tissue. This could involve something akin to what has been
reported in Treg cells, where miR-146a acts as a negative-feedback regulator to restrain IFN-g-mediated pathogenic Th1 responses by targeting directly STAT1 (Lu et al., 2010). IFN-g is
the central cytokine in resistance against Toxoplasma during
both the early and late stages of the infection. However, excessive or inappropriate activation of the IFN-g pathway can be
deleterious to the host. Thus, it appears that overproduction of
IFN-g in the genetically susceptible mice following Toxoplasma
infection can lead to tissue destruction in small intestine and liver
(Liesenfeld et al., 1999). Toxoplasma has developed means to
prevent excessive host damage due to this cytokine. In this
respect, SOCS-1 is induced during Toxoplasma infection and
contributes to the inhibition of IFN-g signaling by the parasite
(Zimmermann et al., 2006). miR-146a may represent an alternative regulatory mechanism to fine-tune the IFN-g-mediated inflammatory response throughout the chronic infection in mouse.
In this model, miR-146a could directly target STAT1 protein
translation or alternatively its upstream negative regulators like
SOCS-1, the latter being previously identified as a downstream
target of its coregulated counterpart, miR-155 (Cardoso et al.,
2012).
In this study, we discovered a characteristic microRNA fingerprint typified by miR-146a and miR-155 that might be involved in
the establishment of latent Toxoplasma infection through the
buffering of the immune response in the brain of the infected
host. Part of the variability of disease outcome in human infections may also be tied to this strain-specific microRNA signature.
In North America and Europe, most human toxoplasmosis cases
are mainly due to type II strains that exhibit a typical miR-146a/
miR-155 signature in mice models. In contrast, type III strains
that are more common in animals and rarely associated with human disease failed to induce these microRNAs in mice brain.
Therefore, it will be important from a clinical point of view to
establish if the aforementioned microRNA signature plays a
role in determining severity of toxoplasmosis in humans.
EXPERIMENTAL PROCEDURES
Mouse and Experimental Infection
Six-week-old Swiss OF1 and BALB/cJRj or 9-week-old C57BL/6JRj mice
were obtained from Charles River Laboratories. Nine-week-old female
B6(FVB)-Mir146tm1.1Bal/J (http://jaxmice.jax.org/strain/016239.html) and
their wild-type littermates (http://jaxmice.jax.org/strain/000664.html) were obtained from The Jackson Laboratory. Mouse care and experimental procedures were performed under pathogen-free conditions in accordance with
established institutional guidance and approved protocols from the
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Institutional Animal Care and Use Committee. The infection protocols are
detailed in Supplemental Experimental Procedures.
T. gondii Transfection
Parasites were transfected using electroporation parameters established previously (Braun et al., 2013).
Western Blot Analysis and Immunofluorescence Microscopy
Immunofluorescence assays and western blots were performed as described
(Braun et al., 2013) using antibodies listed in Supplemental Experimental
Procedures.
Cell Fractionation
Cell fractionation was detailed in Supplemental Experimental Procedures.
MicroRNA Microarray Analyses
HFF cells were left uninfected or infected (MOI = 3) for 6–18 hr with RH or ME49
tachyzoites. RNA was isolated using TRIzol reagent (Invitrogen), followed by
phenol:chloroform:isoamyl extraction. Total RNAs were profiled by Exiqon
(http://www.exiqon.com) using miRCURY LNA arrays. Further processing of
RNAs, hybridization, and analysis of microarray data are in Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.02.002.
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